NCT00361894

Brief Summary

The purpose of this study is to assess if 10 mg Bay 59-7939, taken once daily as a tablet, is safe and prevents blood clot which may form after a knee replacement operation.

Trial Health

98
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Strong global presence with extensive site network
Enrollment
2,531

participants targeted

Target at P75+ for phase_3

Timeline
Completed

Started Feb 2006

Shorter than P25 for phase_3

Geographic Reach
19 countries

143 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2006

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

August 8, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 9, 2006

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2007

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2007

Completed
Last Updated

October 27, 2014

Status Verified

October 1, 2014

Enrollment Period

11 months

First QC Date

August 8, 2006

Last Update Submit

October 24, 2014

Conditions

Outcome Measures

Primary Outcomes (1)

  • Composite endpoint of total VTE i.e.: Any DVT (proximal and/or distal), Non fatal PE, Death of all causes

    Treatment period: up to Day 13+/-4

Secondary Outcomes (8)

  • Incidence of the composite endpoint comprising proximal DVT, non-fatal PE and VTE- related death (major VTE)

    Treatment period: up to Day 13+/-4

  • Incidence of symptomatic VTE (DVT, PE)

    Treatment period: up to Day 13+/-4

  • Incidence of DVT (total, proximal, distal)

    Treatment period: up to Day 13+/-4

  • Incidence of symptomatic VTE during follow-up

    Follow-up period: following 13+/-4 days

  • The composite endpoint comprising major VTE and treatment-emergent major bleeding

    For major VTE, treatment period: up to Day 13+/-4 ; for major bleeding, from first dose of double-blind study medication to up to two days after last dose of double-blind study medication

  • +3 more secondary outcomes

Study Arms (2)

Arm 1

EXPERIMENTAL
Drug: Rivaroxaban (BAY59-7939)

Arm 2

ACTIVE COMPARATOR
Drug: Enoxaparin

Interventions

10 mg rivaroxaban (tablet) once daily administered for 13 +/- 2 days

Arm 1

Syringe of enoxaparin at a dose of 40 mg for 13 +/- 2 days

Arm 2

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (143)

Unknown Facility

Graz, Styria, 8036, Austria

Location

Unknown Facility

Innsbruck, Tyrol, 6020, Austria

Location

Unknown Facility

Linz, Upper Austria, 4010, Austria

Location

Unknown Facility

Vienna, Vienna, 1140, Austria

Location

Unknown Facility

Antwerp, 2020, Belgium

Location

Unknown Facility

Hasselt, 3500, Belgium

Location

Unknown Facility

Liège, 4000, Belgium

Location

Unknown Facility

Merksem, 2170, Belgium

Location

Unknown Facility

Pellenberg, 3212, Belgium

Location

Unknown Facility

Reet, 2840, Belgium

Location

Unknown Facility

Roeselare, 8800, Belgium

Location

Unknown Facility

Penticton, British Columbia, V2A 5C8, Canada

Location

Unknown Facility

Saint John, New Brunswick, E2L 4L2, Canada

Location

Unknown Facility

Burlington, Ontario, L7R 4C4, Canada

Location

Unknown Facility

Kitchener, Ontario, N2G 1G3, Canada

Location

Unknown Facility

Oakville, Ontario, L6J 3M5, Canada

Location

Unknown Facility

Oshawa, Ontario, L1G 2B9, Canada

Location

Unknown Facility

Ottawa, Ontario, K1Y 4E9, Canada

Location

Unknown Facility

Peterborough, Ontario, K9J 7C6, Canada

Location

Unknown Facility

Scarborough Village, Ontario, M1E 4B9, Canada

Location

Unknown Facility

Windsor, Ontario, N9A 1E1, Canada

Location

Unknown Facility

Beijing, 100035, China

Location

Unknown Facility

Beijing, 100044, China

Location

Unknown Facility

Beijing, 100853, China

Location

Unknown Facility

Shanghai, 200025, China

Location

Unknown Facility

Shanghai, 200032, China

Location

Unknown Facility

Shanghai, 200233, China

Location

Unknown Facility

Bogotá, Colombia

Location

Unknown Facility

Cali, Colombia

Location

Unknown Facility

Medellín, Colombia

Location

Unknown Facility

Prague, Tschechien, 180 81, Czechia

Location

Unknown Facility

Brno, 62500, Czechia

Location

Unknown Facility

Chomutov, 430 01, Czechia

Location

Unknown Facility

Havlíčkův Brod, 580 01, Czechia

Location

Unknown Facility

Jihlava, 586 01, Czechia

Location

Unknown Facility

Kolín, 280 00, Czechia

Location

Unknown Facility

Pardubice, 530 03, Czechia

Location

Unknown Facility

Pilsen, 304 60, Czechia

Location

Unknown Facility

Frederiksberg, 2000, Denmark

Location

Unknown Facility

Hellerup, 2900, Denmark

Location

Unknown Facility

Herlev, 2730, Denmark

Location

Unknown Facility

Hørsholm, DK-2970, Denmark

Location

Unknown Facility

Silkeborg, 8600, Denmark

Location

Unknown Facility

Bois-Guillaume, 76230, France

Location

Unknown Facility

Clermont-Ferrand, 63050, France

Location

Unknown Facility

Liévin, 62806, France

Location

Unknown Facility

Marseille, 13008, France

Location

Unknown Facility

Monaco, 98000, France

Location

Unknown Facility

Nantes, 44277, France

Location

Unknown Facility

Nice, 06000, France

Location

Unknown Facility

Nice, 06002, France

Location

Unknown Facility

Paris, 75019, France

Location

Unknown Facility

Paris, 75674, France

Location

Unknown Facility

Paris, 75877, France

Location

Unknown Facility

Paris, 75960, France

Location

Unknown Facility

Soyaux, 16800, France

Location

Unknown Facility

Vandœuvre-lès-Nancy, 54511, France

Location

Unknown Facility

Bad Mergentheim, Baden-Wurttemberg, 97980, Germany

Location

Unknown Facility

Rheinfelden, Baden-Wurttemberg, 79618, Germany

Location

Unknown Facility

Fürth, Bavaria, 90766, Germany

Location

Unknown Facility

Garmisch-Partenkirchen, Bavaria, 82467, Germany

Location

Unknown Facility

Würzburg, Bavaria, 97080, Germany

Location

Unknown Facility

Sommerfeld, Brandenburg, 16766, Germany

Location

Unknown Facility

Bremen, City state Bremen, 28205, Germany

Location

Unknown Facility

Frankfurt am Main, Hesse, 60528, Germany

Location

Unknown Facility

Frankfurt am Main, Hesse, 65929, Germany

Location

Unknown Facility

Düsseldorf, North Rhine-Westphalia, 40225, Germany

Location

Unknown Facility

Witten, North Rhine-Westphalia, 58448, Germany

Location

Unknown Facility

Beersheba, Israel, 84101, Israel

Location

Unknown Facility

Haifa, Israel, 31096, Israel

Location

Unknown Facility

Holon, Israel, 58100, Israel

Location

Unknown Facility

Kfar Saba, Israel, 44281, Israel

Location

Unknown Facility

Tel Aviv, Israel, 64239, Israel

Location

Unknown Facility

Ẕerifin, Israel, 70300, Israel

Location

Unknown Facility

Tel Litwinsky, 52621, Israel

Location

Unknown Facility

San Donato Milanese, Milano, 20097, Italy

Location

Unknown Facility

Abano Terme, Padova, 35031, Italy

Location

Unknown Facility

Gubbio, Perugia, 06024, Italy

Location

Unknown Facility

Alghero, Sassari, 07041, Italy

Location

Unknown Facility

Bologna, 40136, Italy

Location

Unknown Facility

Florence, 50139, Italy

Location

Unknown Facility

Lecco, 23900, Italy

Location

Unknown Facility

Padua, 35127, Italy

Location

Unknown Facility

Parma, 43100, Italy

Location

Unknown Facility

Roma, 00168, Italy

Location

Unknown Facility

Udine, 33100, Italy

Location

Unknown Facility

Varese, 21100, Italy

Location

Unknown Facility

Chihuahua, Chih., Chihuahua, 31000, Mexico

Location

Unknown Facility

Guadalajara, Jalisco, 44280, Mexico

Location

Unknown Facility

Hermosillo, Sonora, 83000, Mexico

Location

Unknown Facility

Amsterdam, 1105 AZ, Netherlands

Location

Unknown Facility

Hilversum, 1213 XZ, Netherlands

Location

Unknown Facility

Hoofddorp, 2134 TM, Netherlands

Location

Unknown Facility

Leiden, 2334 CK, Netherlands

Location

Unknown Facility

Nijmegen, 6522 JV, Netherlands

Location

Unknown Facility

Oss, 5342 BT, Netherlands

Location

Unknown Facility

Zwolle, 8011 JW, Netherlands

Location

Unknown Facility

Elverum, 2409, Norway

Location

Unknown Facility

Gjøvik, 2819, Norway

Location

Unknown Facility

Kongsvinger, 2212, Norway

Location

Unknown Facility

Lillehammer, 2609, Norway

Location

Unknown Facility

Namsos, 7800, Norway

Location

Unknown Facility

Callao, CALLAO 2, Peru

Location

Unknown Facility

Lima, LIMA 11, Peru

Location

Unknown Facility

Lima, LIMA 1, Peru

Location

Unknown Facility

Bialystok, 15-276, Poland

Location

Unknown Facility

Bydgoszcz, 85-094, Poland

Location

Unknown Facility

Gdansk, 80-803, Poland

Location

Unknown Facility

Krakow, 31-826, Poland

Location

Unknown Facility

Lodz, 91-002, Poland

Location

Unknown Facility

Lublin, 20-090, Poland

Location

Unknown Facility

Lublin, 20-718, Poland

Location

Unknown Facility

Szczecin, 71-252, Poland

Location

Unknown Facility

Warsaw, 00-909, Poland

Location

Unknown Facility

Warsaw, 02-637, Poland

Location

Unknown Facility

Bloemfontein, Freestate, 9300, South Africa

Location

Unknown Facility

Johannesburg, Gauteng, 2132, South Africa

Location

Unknown Facility

Pretoria, Gauteng, 0084, South Africa

Location

Unknown Facility

Pretoria, Gauteng, PRETORIA, South Africa

Location

Unknown Facility

Pretoria, Gauteng, South Africa

Location

Unknown Facility

Randburg, Gauteng, 2125, South Africa

Location

Unknown Facility

Durban, KwaZulu-Natal, 4030, South Africa

Location

Unknown Facility

Newcastle, KwaZulu-Natal, 2940, South Africa

Location

Unknown Facility

Somerset West, Western Cape, 7130, South Africa

Location

Unknown Facility

Worcester, Western Cape, 6850, South Africa

Location

Unknown Facility

Badalona, Barcelona, 08916, Spain

Location

Unknown Facility

Barcelona, Barcelona, 08006, Spain

Location

Unknown Facility

Barcelona, Barcelona, 08035, Spain

Location

Unknown Facility

Barcelona, Barcelona, 08036, Spain

Location

Unknown Facility

Castellon, Castellón de La Plana, 12004, Spain

Location

Unknown Facility

Jaén, Jaén, 23007, Spain

Location

Unknown Facility

Alcorcón, Madrid, 28922, Spain

Location

Unknown Facility

Madrid, Madrid, 28040, Spain

Location

Unknown Facility

Pamplona, Pamplona, 31008, Spain

Location

Unknown Facility

Valencia, Valencia, 46010, Spain

Location

Unknown Facility

Falköping, 521 85, Sweden

Location

Unknown Facility

Gothenburg, 416 85, Sweden

Location

Unknown Facility

Halmstad, 301 85, Sweden

Location

Unknown Facility

Hässleholm, 281 25, Sweden

Location

Unknown Facility

Jönköping, 551 85, Sweden

Location

Unknown Facility

Kungälv, 442 83, Sweden

Location

Unknown Facility

Lidköping, 531 85, Sweden

Location

Unknown Facility

Varberg, 432 81, Sweden

Location

Related Publications (1)

  • Lassen MR, Ageno W, Borris LC, Lieberman JR, Rosencher N, Bandel TJ, Misselwitz F, Turpie AG; RECORD3 Investigators. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. N Engl J Med. 2008 Jun 26;358(26):2776-86. doi: 10.1056/NEJMoa076016.

Related Links

MeSH Terms

Conditions

Venous Thromboembolism

Interventions

RivaroxabanEnoxaparin

Condition Hierarchy (Ancestors)

ThromboembolismEmbolism and ThrombosisVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

ThiophenesSulfur CompoundsOrganic ChemicalsMorpholinesOxazinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsHeparin, Low-Molecular-WeightHeparinGlycosaminoglycansPolysaccharidesCarbohydrates

Study Officials

  • Bayer Study Director

    Bayer

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

August 8, 2006

First Posted

August 9, 2006

Study Start

February 1, 2006

Primary Completion

January 1, 2007

Study Completion

January 1, 2007

Last Updated

October 27, 2014

Record last verified: 2014-10

Locations